Enjoy complimentary customisation on priority with our Enterprise License!
Transcriptomics involves the collection and analysis of transcriptomes of different types of cells or tissues present in an organism. A transcriptome characterizes the set of all RNA molecules, which is a part of the genetic code. Transcriptomics has extensive applications in molecular genetics, leading to its augmented demand during the predicted period. The need for specific transcriptomic solutions has resulted in massive investments to develop new technologies, such as microRNA technology, RNAi technology, NGS technology, and RT-PCR technology. These new-age technologies allow researchers to analyze the transcriptional activity of different organisms with higher precision and accuracy. Moreover, advances in transcriptomics technology fuel the demand for innovative and improved data analysis tools and services that can handle huge amounts of transcriptomics data and provide accurate results. According to the market research analysts at Technavio, the global transcriptomics market is expected to grow exponentially at a CAGR of more than 14% over the forecast period.
The increasing prevalence of cardiovascular and CNS disorders and cancer has led to an augmented demand for advanced tools and systems for diagnostics and drug discovery. Gene expression patterns and gene regulation mechanisms, which trigger the functioning and production of proteins can be studied using transcriptomics, and the therapeutic target can be identified more accurately. The increasing demand for personalized medicines and transcriptomics technologies and continuous improvements in healthcare infrastructures are encouraging drug discovery and research. Several biotechnology companies, such as F. Hoffmann-La Roche, Illumina, and Abbott Laboratories are investing heavily in medical research to develop reliable tools and services, which is likely to have a positive impact on the market.
The global transcriptomics market is characterized by the presence of several international and regional vendors. The market is growing steadily with an increase in the number of applications that use transcriptomics testing. The vendors compete on various factors such as price, availability, brand, and variety, where price is set to become a major cause of competition as it enables players to gain an edge in the market. The need for large investments and rapid product innovations are major barriers for the entry of new players. Therefore, vendors must expand geographically and revive domestic demand to achieve sustained growth over time.
Key vendors in this market are -
Other prominent vendors in the market include Beckman Coulter, Becton, Dickinson and Company, Biological Industries, bioMérieux, Bio-Rad Laboratories, Cepheid, Clontech Laboratories, Cytognomix, Edico Genome, Eppendorf, Fluidigm, GE Healthcare, Harvard Bioscience, Kapa Biosystems, Leica Biosystems, Maxim Biotech, Molecular Devices, Oxford Gene Technology, PerkinElmer, Promega, Qiagen, RainDance Technologies, Siemens Healthcare, and Sigma-Aldrich.
During 2015, the transcriptomics consumables segment dominated the market and accounted for more than 56% of the market shares in terms of revenue. The growth of this segment is mainly because of the repeated purchase of reagents, assays, and enzymes for conducting tests. Most of the diagnostic centers that need to carry out a large number of tests for chronic diseases acquire equipment on rent due to high costs. However, they purchase the reagents in large quantities, thus providing revenue opportunities for vendors.
In terms of geography, the Americas led the global transcriptomics market and is expected to hold more than 50% of the revenue market shares by 2020. The growth of this market in the Americas is attributed to the highly developed healthcare infrastructure and the presence of many big pharmaceutical companies, which conduct a high number of testing for new drug development and disease diagnosis. Also, the rising preference for personalized medicines, which use biomarkers developed with the transcriptomic technologies will also fuel the transcriptomics market in the Americas over the forecast period.
Technavio also offers customization on reports based on specific client requirement.
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Market research methodology
PART 04: Introduction
PART 05: Market landscape
PART 06: Market segmentation by product type
PART 07: Market segmentation by technology
PART 08: Market segmentation by PCR technology
PART 09: Geographical segmentation
PART 10: Market drivers
PART 11: Impact of drivers
PART 12: Market challenges
PART 13: Impact of drivers and challenges
PART 14: Market trends
PART 15: Vendor landscape
PART 16: Key Vendor Analysis
PART 17: Appendix
PART 18: Explore Technavio
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.